Search Results

240 results for cmo

CMG Stock Alert: Chipotle Plans to Take a Hit From Bigger Portions

Chipotle stock is on the move Thursday as CMG investors react to the company’s plans to ensure proper portion sizes for customers.

ASML Stock Is Down 20%. Here’s Why You Should Buy ASML Holdings Now.

ASML stock got a reprieve from Biden administration export controls on China, which it derives about half of its total sales.

Facing Reality: AMC Stock Is Headed for Brutality and Fatality

Like a bad movie, AMC stock is heading toward a disappointing ending as AMC Entertainment discloses falling revenue and an earnings loss.

3 Defensive Stocks Worth Buying on the Dip in August

Visa, Altria and Wendy’s are three ideal defensive stocks to buy on the dip for stable returns amid market volatility.

Rivian Investors, Take Note: 2 Key Drivers That Could Boost RIVN’s Profit Outlook

Rivian stock has many upcoming, positive catalysts, meaning investors with longer investment horizons should buy Rivian stock. 

What the Internet Boom Can Tell Us About the Road to AGI

Just as the internet boom created surprising winners, so too will the Road to Artificial General Intelligence (AGI). To illustrate further, let’s consider a separate…

3 Promising Biotech Stocks for the Long-Term: August 2024

Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

SMCI Stock Warning: Why I Am Still Not Buying This Hyper Growth Story

SMCI stock remains unattractive even after a deep correction with stellar growth not associated with positive operating cash flows.

3 Great Growth Stocks to Buy Before Summer Ends

Here are three great growth stocks long-term investors should certainly consider on major pullbacks to amplify portfolio gains.

CMG Stock Analysis: Should You Buy Chipotle Following Its Recent Q2 Report?

Let’s dive into whether CMG stock is worth adding to investor portfolios right now or if now may be the time to pump the brakes.

DXCM Stock Earnings: DexCom Beats EPS, Misses Revenue for Q2 2024

DXCM stock results show that DexCom beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Down 24% In the Past Month, Will AMD Stock Remain In Nvidia’s Shadow?

Can AMD stock deliver gains from here as it faces significant challenges in competing with Nvidia in the AI chips market?

AAPL Stock Outlook: Is Apple’s Shine Fading as Innovation Lags?

Apple stock faces headwinds as Q3 2024 results reveal slowing iPhone sales, challenges in China, and a lack of innovation in AI.

INTC Stock Prediction: Can Intel Survive?

Pat Gelsinger has failed to turn Intel into the chip-making leader it once was. It’s time to keep an eye on INTC stock.

Warren Buffett’s Been Dumping Bank of America Stock. Buy It Anyway.

Even though the Oracle of Omaha’s company sold a lot of Bank of America stock, the outlook is still generally bright for Bank of America.

No Surprises in the CPI Paves the Way for a Rate Cut

3 Augmented Reality Stocks That Could Enhance User Experiences

Investors may want to keep an eye on the long-term trajectory of these three augmented reality stocks as the tech gains adoption.

Why Is American Vanguard (AVD) Stock Down 28% Today?

American Vanguard stock is down on Friday after AVD investors learned of the company missing Q2 estimates and cutting revenue guidance.

Time to Go: 3 Companies Who Should Ditch Their CEOs Immediately

The worst CEOs are often people who stay in the job too long or didn’t do enough in their first year or two to justify…

Why Is Marin Software (MRIN) Stock Up 32% Today?

Marin Software stock is up on Friday with heavy trading of MRIN shares alongside an update to its advertising platform.

3 Infrastructure Stocks to Put on Your Buy List Now

Here are three infrastructure stocks to keep on your buy list in 2024. Jump on the opportunity before they take off.

3 S&P 500 Stocks to Sell Before the Losses Compound

These are some of the S&P 500 stocks to sell that are likely to underperform the market in the long run and hurt investors.

Needham Just Boosted Its Price Target on These 3 Stocks: August 13, 2024

Pay close attention to new stock price targets. While firms won’t always get it right, price upgrades are still worth paying attention to.

Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?

AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.

7 – 10 of 240 results